Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling
- 26 March 2004
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 40 (2), 97-108
- https://doi.org/10.1002/gcc.20018
Abstract
Uterine smooth muscle tumors range from the very common benign leiomyoma to the uncommon, but frequently lethal, leiomyosarcoma. Morphological and clinical differences between these tumors are presumed to result from differences in gene expression. To test this hypothesis, RNAs from four normal uterine myometria, seven uterine leiomyomas, and nine uterine leiomyosarcomas were profiled using microarrays of oligonucleotides representing about 7,000 unique probe sets. RNAs whose levels distinguished any of the three sample types were selected by analysis of variance (ANOVA). The 153 (2.2% of the total) probe sets representing 146 unique genes with the highest test statistic selected for further analysis met minimum ratio and range thresholds between groups. Cluster analysis distinguished benign and malignant samples at the first node, and myometrium and leiomyoma were resolved in a secondary node. Downregulation of specific genes in uterine leiomyosarcoma was the most common pattern of differential gene expression selected by the three‐way ANOVA. Four extrauterine leiomyosarcomas had profiles most similar to that of the uterine leiomyosarcomas. Functional analysis of the 146 genes did not reveal any strong biological theme. These genes were distributed throughout the genome, but there was slight overrepresentation of genes on 1p and 2q. These genes define a tumor signature for uterine smooth muscle neoplasia, and they suggest that the molecular pathways in leiomyoma and leiomyosarcoma are distinct.Keywords
This publication has 22 references indexed in Scilit:
- Differential gene expression in leiomyosarcomaCancer, 2003
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002
- Global Expression Changes of Constitutive and Hormonally Regulated Genes during Endometrial Neoplastic TransformationGynecologic Oncology, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Aberrant Expression of Cyr61, a Member of the CCN (CTGF/Cyr61/Cef10/NOVH) Family, and Dysregulation by 17 -Estradiol and Basic Fibroblast Growth Factor in Human Uterine LeiomyomasJournal of Clinical Endocrinology & Metabolism, 2001
- Human Leiomyoma Smooth Muscle Cells Show Increased Expression of Transforming Growth Factor- 3 (TGF 3) and Altered Responses to the Antiproliferative Effects of TGFJournal of Clinical Endocrinology & Metabolism, 2001
- HMGIC expression in human adult and fetal tissues and in uterine leiomyomataGenes, Chromosomes and Cancer, 1999
- Frequent Loss of Heterozygosity for Chromosome 10 in Uterine Leiomyosarcoma in Contrast to LeiomyomaThe American Journal of Pathology, 1999
- Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomasOncogene, 1997
- Deletion of the Paired α5(IV) and α6(IV) Collagen Genes in Inherited Smooth Muscle TumorsScience, 1993